191 related articles for article (PubMed ID: 18251464)
1. Monoclonal antibody MX35 detects the membrane transporter NaPi2b (SLC34A2) in human carcinomas.
Yin BW; Kiyamova R; Chua R; Caballero OL; Gout I; Gryshkova V; Bhaskaran N; Souchelnytskyi S; Hellman U; Filonenko V; Jungbluth AA; Odunsi K; Lloyd KO; Old LJ; Ritter G
Cancer Immun; 2008 Feb; 8():3. PubMed ID: 18251464
[TBL] [Abstract][Full Text] [Related]
2. Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer.
Lopes dos Santos M; Yeda FP; Tsuruta LR; Horta BB; Pimenta AA; Degaki TL; Soares IC; Tuma MC; Okamoto OK; Alves VA; Old LJ; Ritter G; Moro AM
PLoS One; 2013; 8(7):e70332. PubMed ID: 23936189
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2b.
Levan K; Mehryar M; Mateoiu C; Albertsson P; Bäck T; Sundfeldt K
BMC Cancer; 2017 May; 17(1):303. PubMed ID: 28464843
[TBL] [Abstract][Full Text] [Related]
4. In silico analysis and immunohistochemical characterization of NaPi2b protein expression in ovarian carcinoma with monoclonal antibody Mx35.
Soares IC; Simões K; de Souza JE; Okamoto OK; Wakamatsu A; Tuma M; Ritter G; Alves VA
Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):165-72. PubMed ID: 22553815
[TBL] [Abstract][Full Text] [Related]
5. Generation of monoclonal antibodies against tumor-associated antigen MX35/sodium-dependent phosphate transporter NaPi2b.
Gryshkova V; Lituiev D; Savinska L; Ovcharenko G; Gout I; Filonenko V; Kiyamova R
Hybridoma (Larchmt); 2011 Feb; 30(1):37-42. PubMed ID: 21466284
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of NaPi2b protein (MX35 antigen) expression and subcellular localization in human normal and cancer tissues.
Kiyamova R; Shyian M; Lyzogubov VV; Usenko VS; Gout T; Filonenko V
Exp Oncol; 2011 Sep; 33(3):157-61. PubMed ID: 21956469
[TBL] [Abstract][Full Text] [Related]
7. Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version Rebmab200.
Lindegren S; Andrade LN; Bäck T; Machado CM; Horta BB; Buchpiguel C; Moro AM; Okamoto OK; Jacobsson L; Cederkrantz E; Washiyama K; Aneheim E; Palm S; Jensen H; Tuma MC; Chammas R; Hultborn R; Albertsson P
PLoS One; 2015; 10(5):e0126298. PubMed ID: 25970341
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Development of an Anti-NaPi2b (SLC34A2) Antibody-Drug Conjugate as a Therapeutic for Non-Small Cell Lung and Ovarian Cancers.
Lin K; Rubinfeld B; Zhang C; Firestein R; Harstad E; Roth L; Tsai SP; Schutten M; Xu K; Hristopoulos M; Polakis P
Clin Cancer Res; 2015 Nov; 21(22):5139-50. PubMed ID: 26156394
[TBL] [Abstract][Full Text] [Related]
9. Development of monoclonal antibodies specific for the human sodium-dependent phosphate co-transporter NaPi2b.
Kiyamova R; Gryshkova V; Ovcharenko G; Lituyev D; Malyuchik S; Usenko V; Khozhayenko Y; Gurtovyy V; Yin B; Ritter G; Old L; Filonenko V; Gout I
Hybridoma (Larchmt); 2008 Aug; 27(4):277-84. PubMed ID: 18724815
[TBL] [Abstract][Full Text] [Related]
10. Toward a Topology-Based Therapeutic Design of Membrane Proteins: Validation of NaPi2b Topology in Live Ovarian Cancer Cells.
Bulatova L; Savenkova D; Nurgalieva A; Reshetnikova D; Timonina A; Skripova V; Bogdanov M; Kiyamova R
Front Mol Biosci; 2022; 9():895911. PubMed ID: 35911971
[TBL] [Abstract][Full Text] [Related]
11. Initial immunochemical characterization of MX35 ovarian cancer antigen.
Welshinger M; Yin BW; Lloyd KO
Gynecol Oncol; 1997 Nov; 67(2):188-92. PubMed ID: 9367706
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
[TBL] [Abstract][Full Text] [Related]
13. The study of phosphate transporter NAPI2B expression in different histological types of epithelial ovarian cancer.
Gryshkova V; Goncharuk I; Gurtovyy V; Khozhayenko Y; Nespryadko S; Vorobjova L; Usenko V; Gout I; Filonenko V; Kiyamova R
Exp Oncol; 2009 Mar; 31(1):37-42. PubMed ID: 19300415
[TBL] [Abstract][Full Text] [Related]
14. Sodium-dependent phosphate transporter NaPi2b as a potential predictive marker for targeted therapy of ovarian cancer.
Nurgalieva AK; Popov VE; Skripova VS; Bulatova LF; Savenkova DV; Vlasenkova RA; Safina SZ; Shakirova EZ; Filonenko VV; Bogdanov MV; Kiyamova RG
Biochem Biophys Rep; 2021 Dec; 28():101104. PubMed ID: 34504954
[TBL] [Abstract][Full Text] [Related]
15. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
Mattes MJ; Look K; Furukawa K; Pierce VK; Old LJ; Lewis JL; Lloyd KO
Cancer Res; 1987 Dec; 47(24 Pt 1):6741-50. PubMed ID: 3677104
[TBL] [Abstract][Full Text] [Related]
16. Development of two new monoclonal antibodies reactive to a surface antigen present on human ovarian epithelial cancer cells.
Xu FJ; Yu YH; Li BY; Moradi M; Elg S; Lane C; Carson L; Ramakrishnan S
Cancer Res; 1991 Aug; 51(15):4012-9. PubMed ID: 1855217
[TBL] [Abstract][Full Text] [Related]
17. Distribution of radiolabeled monoclonal antibody MX35 F(ab')2 in tissue samples by storage phosphor screen image analysis: evaluation of antibody localization to micrometastatic disease in epithelial ovarian cancer.
Finstad CL; Lloyd KO; Federici MG; Divgi C; Venkatraman E; Barakat RR; Finn RD; Larson SM; Hoskins WJ; Humm JL
Clin Cancer Res; 1997 Aug; 3(8):1433-42. PubMed ID: 9815829
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein A34, a novel target for antibody-based cancer immunotherapy.
Scanlan MJ; Ritter G; Yin BW; Williams C; Cohen LS; Coplan KA; Fortunato SR; Frosina D; Lee SY; Murray AE; Chua R; Filonenko VV; Sato E; Old LJ; Jungbluth AA
Cancer Immun; 2006 Jan; 6():2. PubMed ID: 16405301
[TBL] [Abstract][Full Text] [Related]
19. Targeting NaPi2b in ovarian cancer.
Banerjee S; Drapkin R; Richardson DL; Birrer M
Cancer Treat Rev; 2023 Jan; 112():102489. PubMed ID: 36446254
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
